EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual Hedgehog/GLI1 and PI3K/Akt/mTOR Targeting Possesses Higher Efficacy to Inhibit T-Cell Acute Lymphoblastic Leukemia Growth

Marica De Chiara, Mariaconcetta Sicurella iD, Mattia Melloni iD, Ilaria Conti iD, Luca Maria Neri iD

Cells · 2025

DOI: 10.3390/cells14241972 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Marica De Chiara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: Zinc Finger Protein GLI1, Proto-Oncogene Proteins c-akt, TOR Serine-Threonine Kinases, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Ferrara, Fondo di Ateneo per la Ricerca Scientifica, Fondazione Di Bella L.M.N.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While the PI3K/Akt/mTOR pathway is a well-established drug target in T-cell acute lymphoblastic leukemia (T-ALL), the contribution of the Hedgehog (Hh) pathway in T-ALL malignancy remains poorly defined. We investigated the effects of pharmacological inhibition of key signaling nodes in these pathways using T-ALL cell lines (Jurkat, Molt-4, DND-41, and ALL-SIL). Cells were treated with the Gli1 inhibitor Gant-61, the Smoothened inhibitors GDC-0449 and Glasdegib, the Akt inhibitor MK-2206, and the mTOR inhibitor RAD001, both alone and in combination. Analyses of cell viability, cell cycle progression, apoptosis, autophagy, protein expression, and in situ intracellular distribution revealed potent cytotoxic activity of Gant-61 and MK-2206, while Smo and mTOR inhibitors showed limited efficacy. Combined Gli1 and Akt inhibition induced synergistic suppression of proliferation, enhanced G0/G1 arrest, increased apoptosis, and promoted autophagy, accompanied by reduced nuclear Gli1 and decreased Akt phosphorylation. These findings demonstrate a functional interaction between Hh/Gli1 and PI3K/Akt pathways in T-ALL and identify Gli1 as a critical, druggable node. Dual targeting of Gli1 and Akt represents a potential therapeutic strategy to overcome resistance and improve treatment outcomes in T-ALL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zinc Finger Protein GLI1Proto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesPrecursor T-Cell Lymphoblastic Leukemia-LymphomaPhosphatidylinositol 3-KinasesHedgehog ProteinsHumansCell ProliferationSignal TransductionCell Line, TumorApoptosisAutophagyHeterocyclic Compounds, 3-RingPyridinesMTOR InhibitorsPyrimidines

Stichwörter der Autor:innen

Hedgehog and PI3K/Akt/mTOR signalingT-cell acute lymphoblastic leukemia (T-ALL)synergistic drug combination

Substanzen

Zinc Finger Protein GLI1Proto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesPhosphatidylinositol 3-KinasesHedgehog ProteinsGLI1 protein, humanGANT 61MK 2206Heterocyclic Compounds, 3-RingMTOR protein, human

Autor:innen und Institutionen

  • Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
  • Department of Environmental Sciences and Prevention, University of Ferrara, 44121 Ferrara, Italy.
  • Department of Chemical, Pharmaceutical, and Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy.
  • LTTA-Electron Microscopy Center, University of Ferrara, 44121 Ferrara, Italy.

ORCID-Profile: Mariaconcetta Sicurella, Mattia Melloni, Ilaria Conti, Luca Maria Neri

Förderung

  • University of Ferrara
  • Fondo di Ateneo per la Ricerca Scientifica
  • Fondazione Di Bella L.M.N
  • Fondo per l’incentivazione alla Ricerca Dipartimentale (FIRD 2022) M.S.

Zitieren

APA

De Chiara, M., Sicurella, M., Melloni, M., Conti, I., & Neri, L. M. (2025). Dual Hedgehog/GLI1 and PI3K/Akt/mTOR Targeting Possesses Higher Efficacy to Inhibit T-Cell Acute Lymphoblastic Leukemia Growth. Cells. https://doi.org/10.3390/cells14241972

Vancouver

De Chiara M, Sicurella M, Melloni M, Conti I, Neri LM. Dual Hedgehog/GLI1 and PI3K/Akt/mTOR Targeting Possesses Higher Efficacy to Inhibit T-Cell Acute Lymphoblastic Leukemia Growth. Cells. 2025. doi:10.3390/cells14241972

BibTeX
@article{DeChiara2025,
  author = {De Chiara, Marica and Sicurella, Mariaconcetta and Melloni, Mattia and Conti, Ilaria and Neri, Luca Maria},
  title = {Dual Hedgehog/GLI1 and PI3K/Akt/mTOR Targeting Possesses Higher Efficacy to Inhibit T-Cell Acute Lymphoblastic Leukemia Growth},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14241972}
}
Kostenlos starten →